MENU
+Compare
SCPX
Stock ticker: ASE
AS OF
Feb 21 closing price
Price
$0.21
Change
+$0.02 (+10.00%)
Capitalization
1.25M

SCPX SCORPIUS HOLDINGS INC. Forecast, Technical & Fundamental Analysis

a clinical stage biopharmaceutical company with interest in the development of novel allogeneic drugs

Industry Biotechnology
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SCPX with price predictions
Feb 21, 2025

SCPX's Stochastic Oscillator is remaining in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SCPX's RSI Oscillator exited the oversold zone, of 49 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SCPX just turned positive on February 12, 2025. Looking at past instances where SCPX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a +4 3-day Advance, the price is estimated to grow further. Considering data from situations where SCPX advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SCPX as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SCPX moved below its 50-day moving average on February 14, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCPX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SCPX broke above its upper Bollinger Band on February 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SCPX entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.043) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). SCPX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.001) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCPX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company with interest in the development of novel allogeneic drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
627 Davis Drive
Phone
+1 919 240-7133
Employees
77
Web
https://www.scorpiusbiologics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
VIDT.X0.0190620.001410
+7.99%
VIDT DAO cryptocurrency
MNOV1.830.06
+3.10%
Medicinova
MTN158.47-0.19
-0.12%
Vail Resorts
FRME43.42-0.68
-1.54%
First Merchants Corp
GRPN12.38-0.60
-4.62%
Groupon

SCPX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPX has been loosely correlated with SPRB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPX
1D Price
Change %
SCPX100%
+5.91%
SPRB - SCPX
43%
Loosely correlated
-1.20%
FENC - SCPX
39%
Loosely correlated
+0.76%
VRPX - SCPX
37%
Loosely correlated
-8.69%
ALVR - SCPX
34%
Loosely correlated
-2.03%
BOLT - SCPX
33%
Loosely correlated
-4.29%
More